ARKG Investment Tracker position change: Decreased position in Regeneron Pharmaceuticals by 140 shares, the number of shares held decreased 1.13% compared to the previous period and now represents 0.63% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 1,780 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 1.01% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 3,910 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 5.42% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 670 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 1.54% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 280 shares, the number of shares held decreased 1.18% compared to the previous period and now represents 1.02% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 13,830 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 3.13% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 130,550 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 1.39% of the total position.
ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 24,430 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 9.59% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 580 shares, the number of shares held decreased 1.18% compared to the previous period and now represents 1.35% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 38,480 shares, the number of shares held decreased 1.17% compared to the previous period and now represents 3.73% of the total position.